THE PROSPECTIVE EVALUATION OF ASYMPTOMATIC PATIENTS SEROPOSITIVE FOR THE HUMAN IMMUNODEFICIENCY VIRUS

被引：0
|
作者：
LONGFIELD, RN [1 ]
HAWKES, C [1 ]
LONGFIELD, JN [1 ]
KELLY, W [1 ]
SLAGLE, D [1 ]
MCALLISTER, CK [1 ]
机构：
[1] BROOKE ARMY MED CTR,INFECT DIS SERV,FT SAM HOUSTON,TX 78234
来源：
CLINICAL RESEARCH | 1988年 / 36卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A21 / A21
页数：1
相关论文
共 50 条
  • [31] Treatment of Cytomegalovirus Retinitis in Human Immunodeficiency Virus Seropositive Patients: Systematic Review
    Narongchai, Chanusnun
    Ausayakhun, Somsanguan
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [32] Psychiatric diagnoses in adolescents seropositive for the human immunodeficiency virus
    Pao, M
    Lyon, M
    D'Angelo, LJ
    Schuman, WB
    Tipnis, T
    Mrazek, DA
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2000, 154 (03): : 240 - 244
  • [33] CANDIDA MENINGITIS IN A HUMAN IMMUNODEFICIENCY VIRUS SEROPOSITIVE FEMALE
    VICH, JAG
    TRUJILLO, FMG
    MARTINEZ, AC
    FERNANDEZ, CJ
    MEDICINA CLINICA, 1989, 93 (18): : 719 - 719
  • [34] ASYMPTOMATIC HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE INDIVIDUALS - EARLY LABORATORY MARKERS IN CEREBROSPINAL-FLUID AND BLOOD
    SINGER, E
    RUANE, P
    RESNICK, L
    SHAPSHAK, P
    SYNDULKO, K
    OSBORNE, M
    RUBINSHTEIN, G
    ROSARIO, I
    SCHMID, P
    TOURTELLOTTE, WW
    ANNALS OF NEUROLOGY, 1988, 24 (01) : 166 - 166
  • [35] Pyrimethamine pharmacokinetics in human immunodeficiency virus-positive patients seropositive for Toxoplasma gondii
    Jacobson, JM
    Davidian, M
    Rainey, PM
    Hafner, R
    Raasch, RH
    Luft, BJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (06) : 1360 - 1365
  • [36] PHARMACOKINETICS OF DIDANOSINE AND KETOCONAZOLE AFTER COADMINISTRATION TO PATIENTS SEROPOSITIVE FOR THE HUMAN-IMMUNODEFICIENCY-VIRUS
    KNUPP, CA
    BRATER, DC
    RELUE, J
    BARBHAIYA, RH
    JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 33 (10): : 912 - 917
  • [37] Pharmacokinetics and absolute bioavailability of oral foscarnet in human immunodeficiency virus-seropositive patients
    Noormohamed, FH
    Youle, MS
    Higgs, CJ
    Martin-Munley, S
    Gazzard, BG
    Lant, AF
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (02) : 293 - 297
  • [38] THALIDOMIDE - TREATMENT OF CHOICE FOR APHTHOUS ULCERS IN PATIENTS SEROPOSITIVE FOR HUMAN-IMMUNODEFICIENCY-VIRUS
    GHIGLIOTTI, G
    REPETTO, T
    FARRIS, A
    ROY, MT
    DEMARCHI, R
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1993, 28 (02) : 271 - 272
  • [39] Cervicovaginal human immunodeficiency virus secretion and plasma viral load in human immunodeficiency virus-seropositive women
    Uvin, SC
    Caliendo, AM
    OBSTETRICS AND GYNECOLOGY, 1997, 90 (05): : 739 - 743
  • [40] Comparison of intestinal function in human immunodeficiency virus-seropositive patients in Kampala and London
    Murphy, B
    Taylor, C
    Crane, R
    Okong, P
    Bjarnason, I
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1999, 34 (05) : 491 - 495
12345